JAZZ vs VECO · P/E 1988, rev $2.28B vs P/E 199, rev $351.8M
Jazz Pharmaceuticals PLC (JAZZ) versus Veeco Instruments Inc (VECO) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Veeco Instruments Inc (VECO) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported VECO revenue for 2026-06-30 was $351.8M. Net income was $11.5M. VECO currently screens at market cap $4.63B and trailing P/E 199.4.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. VECO currently screens at market cap $4.63B and trailing P/E 199.4.
Not investment advice. Open the JAZZ and VECO stock pages for the full models.
Not investment advice.